(Q45138220)

English

Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

M R McCall

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

M La Belle

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

T M Forte

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

R M Krauss

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Y Takanami

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

D L Tribble

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1437

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

23-36

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF)

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

The role of lipoproteins in the degradation of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

The genetic basis of lipoprotein disorders. Introduction and overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

A practical approach to the laboratory diagnosis of dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900177-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0005-2760(98)00177-5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

release_gai66bc4nfdnhgarhyekgblcxu

1 reference

https://api.fatcat.wiki/v0/release/gai66bc4nfdnhgarhyekgblcxu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45138220&oldid=2066766381"